US
Ugur Sahin
Highly Cited Researcher 2025
BioNTech SE, Germany
Ugur Sahin is affiliated with BioNTech SE, where his research centers on mRNA-based immunotherapies for cancer and infectious diseases. He has contributed to the development of mRNA vaccines and individualized cancer immunotherapy approaches.
- Field
- Medicine · Immunology
- Clarivate categories
- Immunology
- Affiliation
- BioNTech SE, Germany